Conference Coverage

Selected liver-transplant patients thrive off immunosuppression

Publish date: October 31, 2016

 

AT WCPGHAN 2016

mzoler@frontlinemedcom.com
On Twitter @mitchelzoler

Pages

Recommended Reading

CD64 validated as biomarker for pediatric Crohn’s disease
MDedge Family Medicine
Vedolizumab shows safety, efficacy for pediatric IBD
MDedge Family Medicine
Frailty stratifies pediatric liver disease severity
MDedge Family Medicine
Ozanimod has lasting effect on ulcerative colitis
MDedge Family Medicine
CMS offering educational webinars on MACRA
MDedge Family Medicine
Plecanatide safe, effective for chronic constipation
MDedge Family Medicine
Automated colonoscopy risk classification for veterans
MDedge Family Medicine
Surgical infections, early discharge hike readmissions in extrahepatic cholangiocarcinoma
MDedge Family Medicine
Data point to optimal window for endoscopy in sicker patients with peptic ulcer bleeding
MDedge Family Medicine
Causes of recurrent pediatric pancreatitis start to emerge
MDedge Family Medicine